(S)-(+)-Ketoprofen Good Manufacturer supply High Quality 22161-81-5
- Molecular Formula:C16H14O3
- Molecular Weight:254.285
- Appearance/Colour:white or almost white, crystalline powder.
- Vapor Pressure:0mmHg at 25°C
- Melting Point:75-78 °C(lit.)
- Refractive Index:1.592
- Boiling Point:431.3 °C at 760 mmHg
- PKA:4.23±0.10(Predicted)
- Flash Point:228.8 °C
- PSA：54.37000
- Density:1.198 g/cm3
- LogP:3.10570
(S)-(+)-Ketoprofen (22161-81-5) Usage
(S)-(+)-Ketoprofen, also known as (S)-2-(3-benzoylphenyl)propionic acid, is a chiral nonsteroidal anti-inflammatory drug (NSAID) that belongs to the class of arylpropionic acids. It is a potent cyclooxygenase (COX) inhibitor and exhibits analgesic, antipyretic, and anti-inflammatory properties. As a white solid, it is the active isomer of the racemic mixture of ketoprofen, which is responsible for its therapeutic effects.
How to get the best price on (S)-(+)-Ketoprofen?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of (S)-(+)-Ketoprofen . You can buy high quality, low price (S)-(+)-Ketoprofen 22161-81-5 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
